GLS and familial pancreatic carcinoma: Furthermore, a recent report revealed that pancreatic cancer cells have compensatory metabolic networks of Gln, exhibiting recovered Gln-derived metabolic intermediates and tumor growth after long-term GLS1 inhibition [72].